Nutritional and metabolic disorders

Applied filters

Nutritional and metabolic disorders

Guidance (69)
- Administering (1)
- Cautions and contraindications (2)
- Excipients (1)
- Porphyria (6)
- Safety in Breastfeeding (35)
- Stability in dosette boxes (51)
- Temperature management (11)
  - Stability outside the fridge (11)
Medicine (71)
- Adapalene (1)
- Agalsidase alfa (1)
- Agalsidase beta (1)
- Albumin human (1)
- Alfacalcidol (1)
- Alglucosidase alfa (1)
- Aluminium hydroxide (2)
- Anagrelide (1)
- Anidulafungin (1)
- Aripiprazole (1)
- Ascorbic acid (1)
- Asfotase alfa (1)
- Atovaquone (1)
- Benralizumab (1)
- Benzoyl peroxide (1)
- Betahistine (1)
- Calcitriol (1)
- Calcium acetate (2)
- Calcium acetate + Magnesium carbonate (1)
- Calcium carbonate (2)
- Calcium gluconate (1)
- Calcium lactate (1)
- Calcium lactate + Calcium phosphate + Ergocalciferol (1)
- Calcium lactate gluconate + Calcium carbonate (1)
- Calcium polystyrene sulfonate (2)
- Caplacizumab (1)
- Carglumic acid (1)
- Carnitine (1)
- Cefepime (1)
- Cefoxitin (1)
- Chloroquine (1)
- Cinacalcet (3)
- Clindamycin (1)
- Colecalciferol (1)
- Colecalciferol + Calcium carbonate (1)
- Cyanocobalamin (1)
- Darbepoetin alfa (1)
- Deferasirox (1)
- Deferiprone (1)
- Demeclocycline (1)
- Diazoxide (1)
- Diclofenac (1)
- Diclofenac potassium (1)
- Diclofenac sodium (1)
- Dimeticone (1)
- Doxycycline (2)
- Efmoroctocog alfa (1)
- Eltrombopag (1)
- Ertugliflozin (1)
- Erythromycin (1)
- Ferrous fumarate (1)
- Ferrous fumarate + Folic acid (1)
- Ferrous gluconate (1)
- Ferrous sulfate (1)
- Ferrous sulfate + Ascorbic acid (1)
- Ferrous sulfate + Folic acid (1)
- Folic acid (1)
- Haem arginate (2)
- Hydroxychloroquine (1)
- Idursulfase (1)
- Isotretinoin (1)
- Ivabradine (1)
- Lactose (1)
- Lanthanum carbonate (1)
- Linaclotide (1)
- Lisdexamfetamine (1)
- Lymecycline (1)
- Magnesium sulfate (1)
- Menadiol (1)
- Mercaptamine (2)
- Meropenem (1)
- Midodrine (1)
- Miglustat (1)
- Nicotinamide + Pyridoxine + Riboflavin + Thiamine (1)
- Nitisinone (1)
- Orlistat (1)
- Paliperidone (1)
- Paricalcitol (1)
- Patiromer calcium (1)
- Penicillamine (1)
- Phosphate (1)
- Phytomenadione (1)
- Potassium chloride (2)
- Prazosin (1)
- Proguanil (1)
- Proguanil + Atovaquone (1)
- Prucalopride (1)
- Pyridoxine (1)
- Quetiapine (1)
- Ribavirin (1)
- Romiplostim (1)
- Sapropterin (1)
- Sarilumab (1)
- Selenium (1)
- Semaglutide (1)
- Sevelamer (2)
- Simeticone (1)
- Sodium acid phosphate + Sodium bicarbonate (1)
- Sodium bicarbonate (2)
- Sodium chloride (2)
- Sodium phenylbutyrate (1)
- Sodium zirconium cyclosilicate (1)
- Thiamine (1)
- Tigecycline (1)
- Tretinoin (1)
- Trientine (2)
- Velaglucerase alfa (1)
- Zinc (1)
- Zinc acetate (1)
- Zinc sulphate (1)
Medicines planning (24)
- New Medicines (11)
  - CCG commissioned new medicines (5)
  - NHS England commissioned new medicines (7)
  - Pre-registration new medicines (UK/EU) (3)
- Patent expiries (21)
Specialty (75)
- Cardiovascular system disorders (2)
- Diabetes (1)
- Ear, nose and throat disorders (1)
- Eyes and vision (2)
- Gastrointestinal disorders (2)
- Haematological disorders (40)
- Liver disorders (1)
- Mental health and illness (2)
- Neurological disorders (1)
- Nutritional and metabolic disorders (75)
- Renal and urologic disorders (3)
- Respiratory disorders (1)
- Skin disorders (2)
- Travel Medicine (1)

Using haem arginate (human hemin) in acute porphyria attacks

21 June 2022Understanding when and how to use haem arginate can help individuals at risk of acute neurovisceral attacks, which though uncommon may be life threatening.

Prescribing in lactose intolerance and how to identify lactose free medicines

17 February 2022Why lactose in medicines is important for healthcare professionals to consider, and how to check lactose content and identify lactose free medicines.

Making safe medicine choices during general anaesthesia and surgery in acute porphyria

26 August 2021Medicines listed as safe should preferably be used. However in a life-threatening situation no drug should be withheld from a patient with porphyria.

What is St Mark's Electrolyte Mix (solution)?

6 November 2020St Mark’s Electrolyte Mix is an unique glucose-electrolyte mix oral rehydration solution (ORS) It is used in the management of short bowel syndrome, to maintain…

Safety in Lactation: Minerals

5 November 2020Maternal mineral supplements pose no risk to breastfed infants when taken in normal doses, although their use should be unnecessary unless the mother’s nutritional status…

Safety in Lactation: Fluids and electrolytes

23 September 2020Oral and intravenous products for correcting fluid and electrolyte imbalance will present no risk to a breastfeeding infant as they are normally present in milk.…

Safety in Lactation: Metabolic disorders

18 September 2020These drugs are used for a variety of metabolic conditions, most of which are rare, and therefore give very limited opportunity to assess their impact…

Medicines that are considered safe for use in the acute porphyrias

29 May 2020The UK Porphyria Medicines Information Service (UKPMIS) and Cardiff Porphyria Service produce a list of medicines that are considered to be safe for use in…

What is the most suitable treatment for acne in a person with acute porphyria?

10 January 2020Topical (applied to the skin) treatments for acne are considered to be safer than oral treatments in people with an acute form of porphyria, provided…

What are the restrictions on prescribing for patients with non-acute porphyria?

20 December 2019Non-acute porphyrias include congenital erythropoietic porphyria, erythropoietic protoporphyria and porphyria cutanea tarda. If a person has an unequivocal diagnosis of congenital erythropoietic porphyria or erythropoietic…

SPS - Specialist Pharmacy Service

NHS